Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]
News [4632]
Articles [192]
Editorials [8]
Conferences [135]
elearning [9]
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for...
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille...
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France )
18 Dec 2013
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia...
Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )
17 Dec 2013
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers...
Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant ( Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany )
16 Dec 2013
Avoiding radiotherapy is an option for some older patients with breast cancer
Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK
Avoiding radiotherapy is an option for some older patients with breast cancer ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )
16 Dec 2013
New agents in CLL
Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013
Chronic lymphocytic leukaemia: A new treatment era is born
Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013
2013 ecancer highlights
Prof Gordon McVie - ecancer and European Institute of Oncology
2013 ecancer highlights ( Prof Gordon McVie - ecancer and European Institute of Oncology )
11 Dec 2013
Patient information needs in biomarkers and biobanking
Francesco de Lorenzo - President of ECPC; Kathi Apostolidis - Vice President of...
Patient information needs in biomarkers and biobanking ( Francesco de Lorenzo - President of ECPC; Kathi Apostolidis - Vice President of ECPC; George Stamatis - Vice President of KEFI; Dr Pauline Evers - Nederlanse Federatie van Kankerpatienteorganisaties )
4 Dec 2013
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome...
Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The...
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )
3 Dec 2013
Cancer cells and the immune system: a natural story?
Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France
Cancer cells and the immune system: a natural story? ( Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France )
3 Dec 2013
Why are Immuno-Oncology compounds different?
Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013
Elderly population needs new definition to inform treatment decisions
Dr Reinhard Stauder, Prof Mario Boccadoro
Elderly population needs new definition to inform treatment decisions ( Dr Reinhard Stauder, Prof Mario Boccadoro )
27 Nov 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation